Lewis R. Silverman, MD: An Overview of Myelodysplastic Syndrome and Personalized Therapies

Lewis R. Silverman, MD: An Overview of Myelodysplastic Syndrome and Personalized Therapies

Lewis R. Silverman, MD, is one of the foremost researchers into myelodysplastic syndrome (MDS), and was the Principal Investigator for the clinical trials which led to FDA approval of azacitidine, the first drug approved for this disease. In this Grand Rounds presentation, Dr. Silverman discusses the causes, gene mutations, progression, and treatments of MDS—as well as the most recent developments in research.


Published

November 27, 2019

Created by

Physician's Channel - Mount Sinai New York

Featured Faculty

Lewis Silverman, MD

Lewis Silverman, MD

Director, Translational Research Center for Myelodysplastic Syndrome, The Tisch Cancer Institute
Associate Professor of Medicine (Hematology and Medical Oncology), and Oncological Sciences

View full profile